diclofenac has been researched along with carbostyril in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Azas, N; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Courtioux, B; Fairlamb, A; Hutter, S; Laget, M; Moreau, A; Mothes, E; Paloque, L; Pedron, J; Pratviel, G; Sournia-Saquet, A; Stigliani, JL; Valentin, A; Vendier, L; Verhaeghe, P; Wyllie, S | 1 |
| Rehavi, M; Rubinstein, E; Segev, S | 1 |
| Jayachandran, C; Kumar, N; Singh, SD | 2 |
| Fukui, H; Takakura, Y; Yajima, H; Yamao, J | 1 |
| Ando, T; Goto, H; Hirooka, Y; Itoh, A; Maeda, O; Nakamura, M; Niwa, Y; Ohmiya, N | 1 |
| Ehara, A; Fujimori, S; Gudis, K; Kobayashi, T; Mitsui, K; Sakamoto, C; Seo, T; Takahashi, Y; Tanaka, S; Tatsuguchi, A; Yonezawa, M | 1 |
| Chen, ML; Diao, L; Hu, J; Jin, J; Liu, XC; Mei, Q; Xu, JM; Yao, Q | 1 |
| Boelsterli, UA; Fujimoto, K; Lee, KK; Redinbo, MR; Saitta, KS; Zhang, C | 1 |
| Amagase, K; Satoh, H; Takeuchi, K | 1 |
| Cooper, DL; Harirforoosh, S; Wood, RC; Wyatt, JE | 1 |
| Bullins, KW; Denham, JW; Hanley, AV; Hanley, GA; Harirforoosh, S; Panus, PC; Wood, RC; Wyatt, JE | 1 |
| Cho, CS; Kang, YM; Kim, JH; Kim, SK; Lee, DH; Lee, SK; Lee, ST; Lee, YC; Park, SH; Park, W; Park, YW; Rew, JS; Yoo, WH | 1 |
| Denham, JW; Harirforoosh, S; Murrell, DE; Panus, PC; Rahmasari, Y | 1 |
| Haraguchi, T; Kojima, H; Li, D; Nakamura, S; Shiraishi, S; Uchida, T; Yoshida, M | 1 |
| Cao, X; Jing, L; Mou, S; Xu, N; Yu, Z; Zhang, C | 1 |
| Hazama, K; Imai, T; Kosuge, Y; Ootsuka, S; Suzuki, S | 1 |
4 trial(s) available for diclofenac and carbostyril
| Article | Year |
|---|---|
Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin and its interaction with diclofenac after intravenous administration in buffalo calves.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Buffaloes; Ciprofloxacin; Diclofenac; Drug Interactions; Enrofloxacin; Female; Fluoroquinolones; Injections, Intravenous; Quinolones | 2003 |
Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Topics: Adult; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Capsule Endoscopy; Cross-Over Studies; Diclofenac; Double-Blind Method; Female; Follow-Up Studies; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Prospective Studies; Quinolones; Severity of Illness Index; Treatment Outcome | 2008 |
Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
Topics: Adult; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Capsule Endoscopy; Diclofenac; Double-Blind Method; Humans; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Omeprazole; Quinolones; Treatment Outcome; Young Adult | 2011 |
Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
Topics: Adult; Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Butanones; Diclofenac; Double-Blind Method; Drug Administration Schedule; Gastric Mucosa; Humans; Meloxicam; Middle Aged; Misoprostol; Nabumetone; Quinolones; Stomach Ulcer; Thiazines; Thiazoles; Treatment Outcome | 2014 |
13 other study(ies) available for diclofenac and carbostyril
| Article | Year |
|---|---|
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
Topics: Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Electrochemical Techniques; Hep G2 Cells; Humans; Kinetoplastida; Leishmania infantum; Molecular Structure; Nitroquinolines; Nitroreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma brucei brucei | 2018 |
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
Topics: Animals; Ciprofloxacin; Diclofenac; Drug Synergism; GABA Antagonists; In Vitro Techniques; Male; Muscimol; Nalidixic Acid; Ofloxacin; Quinolones; Rats; Rats, Inbred Strains; Receptors, GABA-A; Theophylline | 1988 |
Pharmacoknetic study of diclofenac and its interaction with enrofloxacin in buffalo calves.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Buffaloes; Diclofenac; Drug Interactions; Enrofloxacin; Female; Fluoroquinolones; Milk; Quinolones; Tissue Distribution | 2003 |
Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis.
Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Bone Diseases; Cyclooxygenase 2 Inhibitors; Diclofenac; Endoscopy; Famotidine; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Life Style; Male; Middle Aged; Outpatients; Peptic Ulcer; Prospective Studies; Quinolones; Risk Factors | 2007 |
Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Diclofenac; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Mice; Mitochondria; Mitochondrial Swelling; NAD; Permeability; Quinolones; Random Allocation | 2012 |
Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, Liquid; Diclofenac; Enzyme Inhibitors; Glucuronidase; Hepatocytes; Indomethacin; Intestinal Diseases; Intestine, Small; Ketoprofen; Male; Mice; Mice, Inbred C57BL; Quinolones; Statistics, Nonparametric; Tandem Mass Spectrometry; Thiourea | 2014 |
Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Response Relationship, Drug; Gastric Mucins; Gastrointestinal Agents; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Misoprostol; Mucus; Omeprazole; Protective Agents; Proton Pump Inhibitors; Quinolones; Ranitidine; Rats; Rats, Wistar; Sus scrofa; Triazines | 2014 |
Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Celecoxib; Diclofenac; Drug Interactions; Male; Protein Binding; Pyrazoles; Quinolones; Rats; Rats, Sprague-Dawley; Sulfonamides | 2014 |
Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cell Adhesion Molecules; Creatinine; Diclofenac; Dinoprostone; Drug Interactions; Kidney; Kidney Diseases; Male; Nitric Oxide; Potassium; Pyrazoles; Quinolones; Rats; Rats, Sprague-Dawley; Sodium; Sulfonamides | 2013 |
Celecoxib or diclofenac hepatic status in the presence or absence of rebamipide.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Male; Quinolones; Rats; Rats, Sprague-Dawley | 2015 |
Taste-Masking Effect of Chlorogenic Acid (CGA) on Bitter Drugs Evaluated by Taste Sensor and Surface Plasmon Resonance on the Basis of CGA-Drug Interactions.
Topics: Alanine; Amlodipine; Chlorogenic Acid; Diclofenac; Diphenhydramine; Donepezil; Drug Interactions; Etodolac; Indans; Piperidines; Quinolones; Surface Plasmon Resonance; Taste | 2017 |
Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Claudin-1; Cytokines; Diclofenac; Disease Models, Animal; Gene Expression Regulation; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; NF-kappa B; Quinolones; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Ulcer; Zonula Occludens-1 Protein | 2021 |
Preventive effect of rebamipide on NSAID-induced lower gastrointestinal tract injury using FAERS and JADER.
Topics: Adverse Drug Reaction Reporting Systems; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Databases, Factual; Diclofenac; Drug Therapy, Combination; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Japan; Phenylpropionates; Quinolones; United States; United States Food and Drug Administration | 2022 |